Diastolic dysfunction in asymptomatic hemodialysis patients in the light of the current echocardiographic guidelines

Area of Science:

• Nephrology
• Cardiology
• Medical Diagnostics

Background:

• Left ventricular hypertrophy (LVH) is prevalent in end-stage renal disease (ESRD) patients undergoing hemodialysis.
• Diastolic dysfunction frequently develops in these patients, potentially leading to heart failure with preserved ejection fraction.
• Recent American/European echocardiographic guidelines simplify diastolic function assessment.

Purpose of the Study:

• To evaluate if new echocardiographic guidelines can stratify asymptomatic hemodialysis patients based on brain-natriuretic peptide (BNP) levels.
• To investigate the relationship between left ventricular mass, diastolic dysfunction, and BNP levels in this population.

Main Methods:

• Echocardiography and BNP analysis were performed before and after a single hemodialysis session in 46 asymptomatic ESRD patients.
• Patients were free of overt heart failure, systolic dysfunction, arrhythmia, or significant valvular disease.
• Assessment included LVH, diastolic dysfunction grading, and BNP level correlation.

Main Results:

• LVH was present in 53% of patients; higher indexed left ventricular mass correlated significantly with higher BNP levels (r=0.58, p=0.0001).
• Diastolic dysfunction was found in 61% of patients before hemodialysis, with higher grades associated with increased BNP.
• The ratio E/e' medial appeared a better predictor of elevated BNP compared to averaged or lateral E/e' ratios.

Conclusions:

• The current echocardiographic guidelines effectively differentiate asymptomatic hemodialysis patients with preserved systolic function based on BNP levels.
• BNP levels increase with both left ventricular mass and the grade of diastolic dysfunction.
• Echocardiographic assessment of diastolic function using the new guidelines is valuable for risk stratification in hemodialysis patients.